Clinical Trials Browser

Phase 2 × OTHER × 4-fluorobenzoyl-TN-14003 × Clear all

NCT04543071 2025-06-19

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT02907099 2025-02-19

Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

20 enrolled 12 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma

NCT02639559 2023-11-07

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Phase 2 Completed

50 enrolled 23 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02763384 2023-10-31

BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Phase 2 Terminated

12 enrolled 14 charts

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02502968 2015-09-21

BLAST

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute